Page last updated: 2024-09-28

methyl caffeate

Description

methyl caffeate: from plant Gaillardia pulchella [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

methyl caffeate : An alkyl caffeate ester formed by the formal condensation of caffeic acid with methyl alcohol. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
Gaillardiagenus[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Gaillardia pulchellaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID689075
CHEMBL ID17001
CHEBI ID6856
MeSH IDM0125231

Synonyms (49)

Synonym
methyl 1-(3'',4''-dihydroxyphenyl)propenate
3-(3,4-dihydroxy-phenyl)-acrylic acid methyl ester
bdbm50029209
(e)-3-(3,4-dihydroxy-phenyl)-acrylic acid methyl ester
(e)-methyl 3-(3,4-dihydroxyphenyl)acrylate
methyl 3,4-dihydroxycinnamate
methyl (e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
methyl caffeate
3843-74-1
caffeic acid methyl ester
C-1420
methylcaffeate
methyl 3-(3,4-dihydroxyphenyl)acrylate
CHEMBL17001 ,
chebi:6856 ,
methyl 1-(3',4'-dihydroxyphenyl)propenate
methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
AKOS003263230
STK523948
methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
A824271
methyl (e)-3-[3,4-bis(oxidanyl)phenyl]prop-2-enoate
(e)-3-(3,4-dihydroxyphenyl)-2-propenoic acid methyl ester
n79173b9hf ,
unii-n79173b9hf
caffeic acid, methyl ester
2-propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester
67667-67-8
cinnamic acid, 3,4-dihydroxy-, methyl ester
methyl-3,4-dihydroxy cinnamate
J-502041
methyl (2e)-3-(3,4-dihydroxyphenyl)acrylate
2-propenoic acid, 3-(3,4-dihydroxyphenyl)-, methyl ester, (e)-
142234-81-9
mfcd00210468
AS-65428
e-caffeic acid methyl ester
(e)-3,4-dihydroxycinnamic acid methyl ester
(e)-methyl3-(3,4-dihydroxyphenyl)acrylate
(e)-caffeic acid methyl ester
Q6823935
methyl caffeate acid
methyl (e)-3-(3,4-dihydroxyphenyl)acrylate
AC9787
AS-56651
E80647
DTXSID401030290
CS-0032054
HY-N6005

Treatment

ExcerptReference
"Methyl caffeate treated diabetic rats showed upregulation of GLUT4 and regeneration of β-cells in the pancreas."( Gandhi, GR; Ignacimuthu, S; Paulraj, MG; Sasikumar, P, 2011)

Drug Classes (2)

ClassDescription
alkyl caffeate esterA cinnamate ester obtained by formal condensation of caffeic acid with any alkyl alcohol.
methyl esterAny carboxylic ester resulting from the formal condensation of a carboxy group with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
3-oxoacyl-Pseudomonas aeruginosaIC50 (µMol)51.00002.00002.00002.0000AID1191123
Integrase Human immunodeficiency virus 1IC50 (µMol)100.00000.00051.544310.0000AID371216; AID91430; AID91579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TransthyretinHomo sapiens (human)EC50 (µMol)67.00005.60007.54298.6000AID1169291
Amyloid-beta precursor proteinHomo sapiens (human)EC50 (µMol)67.70000.00074.20538.4100AID1500513
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Substance-P receptorCavia porcellus (domestic guinea pig)CD22.00000.90004.50009.8000AID144377
Quinone oxidoreductaseMus musculus (house mouse)CD22.00000.20002.74219.8000AID144377
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (81)

Processvia Protein(s)Taxonomy
signal transductionTransthyretinHomo sapiens (human)
purine nucleobase metabolic processTransthyretinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
cognitionAmyloid-beta precursor proteinHomo sapiens (human)
G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglial cell activationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
suckling behaviorAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activation involved in immune responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of translationAmyloid-beta precursor proteinHomo sapiens (human)
protein phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
intracellular copper ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
endocytosisAmyloid-beta precursor proteinHomo sapiens (human)
response to oxidative stressAmyloid-beta precursor proteinHomo sapiens (human)
cell adhesionAmyloid-beta precursor proteinHomo sapiens (human)
regulation of epidermal growth factor-activated receptor activityAmyloid-beta precursor proteinHomo sapiens (human)
Notch signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
axonogenesisAmyloid-beta precursor proteinHomo sapiens (human)
learning or memoryAmyloid-beta precursor proteinHomo sapiens (human)
learningAmyloid-beta precursor proteinHomo sapiens (human)
mating behaviorAmyloid-beta precursor proteinHomo sapiens (human)
locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
axo-dendritic transportAmyloid-beta precursor proteinHomo sapiens (human)
cholesterol metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of cell population proliferationAmyloid-beta precursor proteinHomo sapiens (human)
adult locomotory behaviorAmyloid-beta precursor proteinHomo sapiens (human)
visual learningAmyloid-beta precursor proteinHomo sapiens (human)
regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of gene expressionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-threonine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
microglia developmentAmyloid-beta precursor proteinHomo sapiens (human)
axon midline choice point recognitionAmyloid-beta precursor proteinHomo sapiens (human)
neuron remodelingAmyloid-beta precursor proteinHomo sapiens (human)
dendrite developmentAmyloid-beta precursor proteinHomo sapiens (human)
regulation of Wnt signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
extracellular matrix organizationAmyloid-beta precursor proteinHomo sapiens (human)
forebrain developmentAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection developmentAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of chemokine productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-1 beta productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of interleukin-6 productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of tumor necrosis factor productionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of multicellular organism growthAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of neuron differentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of glycolytic processAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of mitotic cell cycleAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of JNK cascadeAmyloid-beta precursor proteinHomo sapiens (human)
astrocyte activationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of long-term neuronal synaptic plasticityAmyloid-beta precursor proteinHomo sapiens (human)
collateral sprouting in absence of injuryAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of inflammatory responseAmyloid-beta precursor proteinHomo sapiens (human)
regulation of peptidyl-tyrosine phosphorylationAmyloid-beta precursor proteinHomo sapiens (human)
regulation of synapse structure or activityAmyloid-beta precursor proteinHomo sapiens (human)
synapse organizationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of calcium-mediated signalingAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular process controlling balanceAmyloid-beta precursor proteinHomo sapiens (human)
synaptic assembly at neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of protein metabolic processAmyloid-beta precursor proteinHomo sapiens (human)
neuron apoptotic processAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulum calcium ion homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
neuron cellular homeostasisAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeAmyloid-beta precursor proteinHomo sapiens (human)
response to interleukin-1Amyloid-beta precursor proteinHomo sapiens (human)
modulation of excitatory postsynaptic potentialAmyloid-beta precursor proteinHomo sapiens (human)
NMDA selective glutamate receptor signaling pathwayAmyloid-beta precursor proteinHomo sapiens (human)
regulation of spontaneous synaptic transmissionAmyloid-beta precursor proteinHomo sapiens (human)
cytosolic mRNA polyadenylationAmyloid-beta precursor proteinHomo sapiens (human)
negative regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of long-term synaptic potentiationAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of non-canonical NF-kappaB signal transductionAmyloid-beta precursor proteinHomo sapiens (human)
cellular response to amyloid-betaAmyloid-beta precursor proteinHomo sapiens (human)
regulation of presynapse assemblyAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
amyloid fibril formationAmyloid-beta precursor proteinHomo sapiens (human)
neuron projection maintenanceAmyloid-beta precursor proteinHomo sapiens (human)
positive regulation of T cell migrationAmyloid-beta precursor proteinHomo sapiens (human)
central nervous system developmentAmyloid-beta precursor proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
hormone activityTransthyretinHomo sapiens (human)
protein bindingTransthyretinHomo sapiens (human)
identical protein bindingTransthyretinHomo sapiens (human)
thyroid hormone bindingTransthyretinHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
DNA bindingAmyloid-beta precursor proteinHomo sapiens (human)
serine-type endopeptidase inhibitor activityAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
heparin bindingAmyloid-beta precursor proteinHomo sapiens (human)
enzyme bindingAmyloid-beta precursor proteinHomo sapiens (human)
identical protein bindingAmyloid-beta precursor proteinHomo sapiens (human)
transition metal ion bindingAmyloid-beta precursor proteinHomo sapiens (human)
receptor ligand activityAmyloid-beta precursor proteinHomo sapiens (human)
PTB domain bindingAmyloid-beta precursor proteinHomo sapiens (human)
protein serine/threonine kinase bindingAmyloid-beta precursor proteinHomo sapiens (human)
signaling receptor activator activityAmyloid-beta precursor proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (42)

Processvia Protein(s)Taxonomy
extracellular regionTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
azurophil granule lumenTransthyretinHomo sapiens (human)
extracellular exosomeTransthyretinHomo sapiens (human)
extracellular spaceTransthyretinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
dendriteAmyloid-beta precursor proteinHomo sapiens (human)
extracellular regionAmyloid-beta precursor proteinHomo sapiens (human)
extracellular spaceAmyloid-beta precursor proteinHomo sapiens (human)
nuclear envelope lumenAmyloid-beta precursor proteinHomo sapiens (human)
cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
mitochondrial inner membraneAmyloid-beta precursor proteinHomo sapiens (human)
endosomeAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
endoplasmic reticulum lumenAmyloid-beta precursor proteinHomo sapiens (human)
smooth endoplasmic reticulumAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
Golgi lumenAmyloid-beta precursor proteinHomo sapiens (human)
Golgi-associated vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cytosolAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
clathrin-coated pitAmyloid-beta precursor proteinHomo sapiens (human)
cell-cell junctionAmyloid-beta precursor proteinHomo sapiens (human)
synaptic vesicleAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
membraneAmyloid-beta precursor proteinHomo sapiens (human)
COPII-coated ER to Golgi transport vesicleAmyloid-beta precursor proteinHomo sapiens (human)
axonAmyloid-beta precursor proteinHomo sapiens (human)
growth coneAmyloid-beta precursor proteinHomo sapiens (human)
platelet alpha granule lumenAmyloid-beta precursor proteinHomo sapiens (human)
neuromuscular junctionAmyloid-beta precursor proteinHomo sapiens (human)
endosome lumenAmyloid-beta precursor proteinHomo sapiens (human)
trans-Golgi network membraneAmyloid-beta precursor proteinHomo sapiens (human)
ciliary rootletAmyloid-beta precursor proteinHomo sapiens (human)
dendritic spineAmyloid-beta precursor proteinHomo sapiens (human)
dendritic shaftAmyloid-beta precursor proteinHomo sapiens (human)
perikaryonAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
apical part of cellAmyloid-beta precursor proteinHomo sapiens (human)
synapseAmyloid-beta precursor proteinHomo sapiens (human)
perinuclear region of cytoplasmAmyloid-beta precursor proteinHomo sapiens (human)
presynaptic active zoneAmyloid-beta precursor proteinHomo sapiens (human)
spindle midzoneAmyloid-beta precursor proteinHomo sapiens (human)
recycling endosomeAmyloid-beta precursor proteinHomo sapiens (human)
extracellular exosomeAmyloid-beta precursor proteinHomo sapiens (human)
receptor complexAmyloid-beta precursor proteinHomo sapiens (human)
early endosomeAmyloid-beta precursor proteinHomo sapiens (human)
membrane raftAmyloid-beta precursor proteinHomo sapiens (human)
cell surfaceAmyloid-beta precursor proteinHomo sapiens (human)
Golgi apparatusAmyloid-beta precursor proteinHomo sapiens (human)
plasma membraneAmyloid-beta precursor proteinHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (75)

Assay IDTitleYearJournalArticle
AID684438Cytotoxicity against human A549 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID684445Cytotoxicity against human 292G cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID713894Antimycobacterial activity against Mycobacterium tuberculosis H37Ra2012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID1169299Competitive binding to TTR V30M mutant (unknown origin) expressed in Escherichia coli at 1 to 80 uM by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1161637Antitumor activity against human SGC7901 cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1070390Cytotoxicity against mouse HT22 cells assessed as cell viability at 40 uM after 24 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1766075Cytotoxicity against in mouse 3T3-L1 cells assessed as reduction in cell viability at 100 uM incubated for 24 hrs by MTT assay relative to control2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Phytochemicals from the flowers of Prunus persica (L.) Batsch: Anti-adipogenic effect of mandelamide on 3T3-L1 preadipocytes.
AID1766076Inhibition of preadipocyte differentiation in mouse 3T3-L1 cells assessed as lipid droplet accumulation at 100 uM incubated for 8 days by Oil Red O staining method relative to untreated control2021Bioorganic & medicinal chemistry letters, 10-01, Volume: 49Phytochemicals from the flowers of Prunus persica (L.) Batsch: Anti-adipogenic effect of mandelamide on 3T3-L1 preadipocytes.
AID780242Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs by WST-1 assay2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
AID1370495Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitro-phenyl-alpha-D-glucopyranoside as substrate preincubated with enzyme followed by substrate addition measured after 10 mins for every 2.5 to 5 mins2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
AID1161633Antitumor activity against human HeLa cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID91430In vitro inhibitory activity against HIV-1 integrase.1995Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21
Hydroxylated aromatic inhibitors of HIV-1 integrase.
AID436320Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs2008Journal of natural products, Nov, Volume: 71, Issue:11
Phenylpropanoids from Daphne feddei and their inhibitory activities against NO production.
AID80256Inhibitory concentration against HCT 116 human colon cancer cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1161638Antitumor activity against human HepG2 cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1161634Antitumor activity against human SiHa cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1070388Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 20 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID750755Inhibition of Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus laevis oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents at 1 mM after 30 secs by voltage clamp technique2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Identification of cinnamic acid derivatives as novel antagonists of the prokaryotic proton-gated ion channel GLIC.
AID158873In vitro antimalarial activity against Plasmodium falciparum1995Journal of medicinal chemistry, Jun-23, Volume: 38, Issue:13
Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators.
AID333315Cytotoxicity against human doxorubicin-resistant LoVo cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1500523Antioxidant activity assessed as inhibition of DPPH radical at 100 uM incubated for 20 mins measured for 60 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID684448Cytotoxicity against human M14 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1076848Antifungal activity against early stage preformed Candida albicans ATCC 10231 biofilm by XTT reduction assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID1498663Cytoprotective activity against 100 uM t-BHP-induced oxidative stress in human HepG2 cells assessed as cell viability preincubated for 1 hr followed by t-BHP addition measured after 3 hrs by CCK-8 assay (Rvb = 22%)2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
Synthesis of coumarin derivatives and their cytoprotective effects on t-BHP-induced oxidative damage in HepG2 cells.
AID684450Cytotoxicity against human M4E cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1191127Inhibition of Pseudomonas aeruginosa PA14 PqsH transposon mutant assessed as extracellular level of HHQ after 16 hrs2015European journal of medicinal chemistry, Jan-27, Volume: 90Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD.
AID1500513Inhibition of QD-labeled amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by inverted fluorescence microscopic method2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID684451Cytotoxicity against human SKBR cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID684443Cytotoxicity against human HOP62 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID780232Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins by spectrophotometry2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
AID1500524Antioxidant activity assessed as inhibition of DPPH radical at 500 uM incubated for 20 mins measured for 60 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID684440Cytotoxicity against human H460 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1498666Antioxidant activity assessed as DPPH radical scavenging activity measured after 30 mins2018Bioorganic & medicinal chemistry letters, 08-01, Volume: 28, Issue:14
Synthesis of coumarin derivatives and their cytoprotective effects on t-BHP-induced oxidative damage in HepG2 cells.
AID684442Cytotoxicity against human H266 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID333312Cytotoxicity against human HL60 cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1617647Antiinflammatory activity against LPS-stimulated mouse RAW264.7 cells assessed as decrease in PGE2 production preincubated for 1 hr followed by LPS stimulation and measured after 24 hrs by ELISA
AID684444Cytotoxicity against human NCI-H1299 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1070389Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured for 20 hrs by time-resolved ECIS analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID780231Antiproliferative activity against human LNCAP cells at 1 to 10 uM after 72 hrs in presence of DHT2013Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue:22
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
AID362056Cytotoxicity against mouse RAW264.7 cells assessed as cell survival after 24 hrs by MTT assay2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
AID1161635Antitumor activity against human Bewo cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID1169291Inhibition of TTR V30M mutant (unknown origin) expressed in Escherichia coli assessed as inhibition of amyloid fibril formation by fluorescence assay2014Journal of medicinal chemistry, Nov-13, Volume: 57, Issue:21
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
AID1076849Inhibition of biofilm formation of Candida albicans ATCC 10231 by XTT reduction assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID449642Antinociceptive activity in Swiss mouse by inhibition of acetic acid-induced abdominal constriction at 10 mg/kg, ip after 20 mins2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antinociceptive properties of caffeic acid derivatives in mice.
AID1500521Inhibition of butter milk XOD (unknown origin) at 10 uM using xanthine as substrate after 8 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID333314Cytotoxicity against human LoVo cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID1623812Cytotoxicity against mouse L5178 cells assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID684446Cytotoxicity against human Calu1 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID144377Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.1998Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
AID1076846Antifungal activity against planktonically grown Candida albicans ATCC 10231 by CLSI M27 A3 broth microdilution method2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID362057Inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells assessed as nitrite accumulation administered 1 hr before LPS challenge and measured after 24 hrs by Griess reagent assay2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
AID1191123Inhibition of Pseudomonas aeruginosa recombinant PqsD expressed in Escherichia coli BL21 (lambdaDE3) using ACoA/beta-ketodecanoic acid as substrate after 10 mins2015European journal of medicinal chemistry, Jan-27, Volume: 90Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD.
AID684439Cytotoxicity against human NCI-H157 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1161636Antitumor activity against human HL60 cells assessed as inhibition of cell growth by MTT assay2014Bioorganic & medicinal chemistry letters, Sep-15, Volume: 24, Issue:18
Synthesis and antitumor activity of feruloyl and caffeoyl derivatives.
AID449663Lipophilicity, log P of the compound2009European journal of medicinal chemistry, Nov, Volume: 44, Issue:11
Antinociceptive properties of caffeic acid derivatives in mice.
AID750756Antagonist activity at Gloeobacter violaceus ligand-gated ion channel expressed in Xenopus oocytes assessed as inhibition of MES buffer pH 5.5 -induced currents after 30 secs by voltage clamp technique2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Identification of cinnamic acid derivatives as novel antagonists of the prokaryotic proton-gated ion channel GLIC.
AID1370496Inhibition of Saccharomyces cerevisiae alpha-glucosidase using p-nitro-phenyl-alpha-D-glucopyranoside as substrate at 200 uM preincubated with enzyme followed by substrate addition measured after 10 mins for every 2.5 to 5 mins relative to control2018Bioorganic & medicinal chemistry letters, 02-01, Volume: 28, Issue:3
Chemical constituents from Taraxacum officinale and their α-glucosidase inhibitory activities.
AID1076847Antifungal activity against mature preformed Candida albicans ATCC 10231 biofilm by XTT reduction assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID362058Ratio of EC50 for mouse RAW264.7 cells to EC50 for inhibition of LPS-induced nitric oxide production in mouse RAW264.7 cells2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
Inhibitory effect of the alkyl side chain of caffeic acid analogues on lipopolysaccharide-induced nitric oxide production in RAW264.7 macrophages.
AID1500522Inhibition of butter milk XOD (unknown origin) at 100 uM using xanthine as substrate after 8 mins relative to control2017European journal of medicinal chemistry, Sep-29, Volume: 138Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
AID39252Inhibitory concentration against B16 murine melanoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID8620Inhibitory concentration required against A 431 human epidermoid carcinoma cell line2001Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue:9
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
AID1070384Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 9 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1191126Binding affinity to Pseudomonas aeruginosa recombinant his6-tagged PqsD expressed in Escherichia coli BL21 (lambdaDE3) using AcoA as substrate at 250 to 500 uM incubated for 40 mins prior to compound addition followed by wash out for 30 mins by SPR analys2015European journal of medicinal chemistry, Jan-27, Volume: 90Catechol-based substrates of chalcone synthase as a scaffold for novel inhibitors of PqsD.
AID290547Antitumor activity against KB cells by MTT assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Synthesis and biological evaluation of 12 allenic aromatic ethers.
AID1623813Cytotoxicity against mouse L5178B1 cells transfected with pHa MDR1/A retrovirus assessed as reduction in cell viability after 72 hrs by MTT assay2019Journal of medicinal chemistry, 02-14, Volume: 62, Issue:3
Antioxidant-Inspired Drug Discovery: Antitumor Metabolite Is Formed in Situ from a Hydroxycinnamic Acid Derivative upon Free-Radical Scavenging.
AID333313Cytotoxicity against human HT1080 cells after 72 hrs by MTT assay2004Journal of natural products, Sep, Volume: 67, Issue:9
Cytotoxic constituents of roots of Chaerophyllum hirsutum.
AID684447Cytotoxicity against human LOXIMVI cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID290548Antitumor activity against KBv200 cells by MTT assay2007Bioorganic & medicinal chemistry letters, May-15, Volume: 17, Issue:10
Synthesis and biological evaluation of 12 allenic aromatic ethers.
AID371216Inhibition of HIV1 integrase by ELISA2008Bioorganic & medicinal chemistry letters, Dec-15, Volume: 18, Issue:24
Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.
AID91579Inhibitory activity against HIV-1 Integrase (HIV-1-IN)2002Journal of medicinal chemistry, Feb-14, Volume: 45, Issue:4
CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.
AID592088Antihemorrhagic activity in ddY mouse assessed as inhibition of Protobothrops flavoviridis venom-induced hemorrhage incubated with compound for 10 mins measured after 24 hrs2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Contribution of cinnamic acid analogues in rosmarinic acid to inhibition of snake venom induced hemorrhage.
AID684441Cytotoxicity against human NCI-H1792 cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
AID1076845Cytotoxicity against human NCI-H292 cells assessed as reduction in viable cells by MTT assay2014Bioorganic & medicinal chemistry letters, Mar-15, Volume: 24, Issue:6
Activity of caffeic acid derivatives against Candida albicans biofilm.
AID684449Cytotoxicity against human HeLa cells after 72 hrs by alamar blue assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
Biological activity evaluation and structure-activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.37)18.7374
1990's3 (4.11)18.2507
2000's15 (20.55)29.6817
2010's48 (65.75)24.3611
2020's6 (8.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.37%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (98.63%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Safety/Toxicity (2)

ArticleYear
Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Bioorganic & medicinal chemistry, Nov-15, Volume: 21, Issue: 22
2013
Syntheses of certain 3-aryl-2-propenoates and evaluation of their cytotoxicity.
Bioorganic & medicinal chemistry letters, May-07, Volume: 11, Issue: 9
2001
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]